These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 35672901)
21. R125H, W240S, C386R, and V507I SLC4A11 mutations associated with corneal endothelial dystrophy affect the transporter function but not trafficking in PS120 cells. Li S; Hundal KS; Chen X; Choi M; Ogando DG; Obukhov AG; Bonanno JA Exp Eye Res; 2019 Mar; 180():86-91. PubMed ID: 30557570 [TBL] [Abstract][Full Text] [Related]
22. Mutation in the SLC4A11 gene associated with autosomal recessive congenital hereditary endothelial dystrophy in a large Saudi family. Shah SS; Al-Rajhi A; Brandt JD; Mannis MJ; Roos B; Sheffield VC; Syed NA; Stone EM; Fingert JH Ophthalmic Genet; 2008 Mar; 29(1):41-5. PubMed ID: 18363173 [TBL] [Abstract][Full Text] [Related]
33. Missense mutations in the sodium borate cotransporter SLC4A11 cause late-onset Fuchs corneal dystrophy. Riazuddin SA; Vithana EN; Seet LF; Liu Y; Al-Saif A; Koh LW; Heng YM; Aung T; Meadows DN; Eghrari AO; Gottsch JD; Katsanis N Hum Mutat; 2010 Nov; 31(11):1261-8. PubMed ID: 20848555 [TBL] [Abstract][Full Text] [Related]
34. Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy. Salman M; Verma A; Chaurasia S; Prasad D; Kannabiran C; Singh V; Ramappa M Orphanet J Rare Dis; 2022 Sep; 17(1):361. PubMed ID: 36115991 [TBL] [Abstract][Full Text] [Related]
35. Compound heterozygous mutations in the Liu M; Xia JL; Yang H; Yu L Ophthalmic Genet; 2022 Aug; 43(4):538-542. PubMed ID: 35291925 [TBL] [Abstract][Full Text] [Related]
36. Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy. Hemadevi B; Veitia RA; Srinivasan M; Arunkumar J; Prajna NV; Lesaffre C; Sundaresan P Arch Ophthalmol; 2008 May; 126(5):700-8. PubMed ID: 18474783 [TBL] [Abstract][Full Text] [Related]
37. Ophthalmic Nonsteroidal Anti-Inflammatory Drugs as a Therapy for Corneal Dystrophies Caused by SLC4A11 Mutation. Alka K; Casey JR Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4258-4267. PubMed ID: 30140924 [TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of the SLC4A11 gene in Indian families with congenital hereditary endothelial dystrophy 2 and a review of the literature. Kodaganur SG; Kapoor S; Veerappa AM; Tontanahal SJ; Sarda A; Yathish S; Prakash DR; Kumar A Mol Vis; 2013; 19():1694-706. PubMed ID: 23922488 [TBL] [Abstract][Full Text] [Related]
40. A biochemical framework for SLC4A11, the plasma membrane protein defective in corneal dystrophies. Vilas GL; Morgan PE; Loganathan SK; Quon A; Casey JR Biochemistry; 2011 Mar; 50(12):2157-69. PubMed ID: 21288032 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]